Compass Therapeutics, Inc. (CMPX)
0.8967
+0.02
(+2.01%)
USD |
NASDAQ |
Oct 15, 16:00
0.89
-0.01
(-0.75%)
After-Hours: 20:00
Compass Therapeutics Cash from Operations (TTM) : -56.11M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.11M |
| March 31, 2026 | -53.20M |
| December 31, 2025 | -49.14M |
| September 30, 2025 | -45.05M |
| June 30, 2025 | -45.25M |
| March 31, 2025 | -44.18M |
| December 31, 2024 | -44.86M |
| September 30, 2024 | -48.05M |
| June 30, 2024 | -42.92M |
| March 31, 2024 | -42.28M |
| December 31, 2023 | -40.62M |
| September 30, 2023 | -38.90M |
| June 30, 2023 | -43.92M |
| March 31, 2023 | -38.41M |
| Date | Value |
|---|---|
| December 31, 2022 | -34.12M |
| September 30, 2022 | -28.15M |
| June 30, 2022 | -20.66M |
| March 31, 2022 | -22.00M |
| December 31, 2021 | -19.67M |
| September 30, 2021 | -21.57M |
| June 30, 2021 | -25.29M |
| March 31, 2021 | -24.65M |
| December 31, 2020 | -26.80M |
| September 30, 2020 | -25.82M |
| June 30, 2020 | -25.36M |
| March 31, 2020 | -29.02M |
| December 31, 2019 | -31.74M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Viking Therapeutics, Inc. | -418.44M |
| Capricor Therapeutics, Inc. | -104.00M |
| Ardelyx, Inc. | -17.32M |
| Biomea Fusion, Inc. | -47.06M |
| ARS Pharmaceuticals, Inc. | -196.40M |